$267.76
1.26% yesterday
NYSE, Jun 25, 10:10 pm CET
ISIN
US79466L3024
Symbol
CRM

Salesforce Target price 2025 - Analyst rating & recommendation

Salesforce Classifications & Recommendation:

Buy
81%
Hold
15%
Sell
3%

Salesforce Price Target

Target Price $351.24
Price $267.76
Potential 31.18%
Number of Estimates 50
50 Analysts have issued a price target Salesforce 2026 . The average Salesforce target price is $351.24. This is 31.18% higher than the current stock price. The highest price target is $440.00 64.33% , the lowest is $225.00 15.97% .
A rating was issued by 59 analysts: 48 Analysts recommend Salesforce to buy, 9 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2026 of 31.18% . Most analysts recommend the Salesforce stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030


Apr '24 Jul '25
Estimates
Revenue Billion $ 9.13 10.13
10.74% 10.96%
EBITDA Margin 21.24% 42.00%
30.15% 97.72%
Net Margin 16.79% 17.09%
595.62% 1.82%

52 Analysts have issued a sales forecast Salesforce 2026 . The average Salesforce sales estimate is $41.2b . This is 6.74% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $41.6b 7.80% , the lowest is $40.8b 5.68% .

This results in the following potential growth metrics:

Revenue Estimates

2025 $37.9b 8.72%
2026 $41.2b 8.71%
2027 $44.9b 9.08%
2028 $49.5b 10.20%
2029 $55.9b 12.90%
2030 $60.1b 7.51%

14 Analysts have issued an Salesforce EBITDA forecast 2026. The average Salesforce EBITDA estimate is $17.1b . This is 94.03% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.6b 110.67% , the lowest is $15.9b 80.75% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $8.6b 24.34%
2026 $17.1b 99.83%
2027 $18.6b 8.58%
2028 $20.6b 11.01%
2029 $24.4b 18.27%
2030 $26.6b 8.96%

EBITDA Margin

2025 22.61% 14.37%
2026 41.56% 83.84%
2027 41.36% 0.48%
2028 41.67% 0.75%
2029 43.65% 4.75%
2030 44.24% 1.35%

25 Salesforce Analysts have issued a net profit forecast 2026. The average Salesforce net profit estimate is $6.9b . This is 11.78% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $7.3b 18.45% , the lowest is $6.5b 4.06% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $6.2b 49.83%
2026 $6.9b 11.93%
2027 $8.1b 16.76%
2028 $10.0b 23.52%
2029 $13.7b 36.49%

Net Margin

2025 16.35% 37.82%
2026 16.84% 2.98%
2027 18.02% 7.01%
2028 20.20% 12.10%
2029 24.42% 20.89%

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030


Apr '24 Jul '25
Estimates
Earnings Per Share $ 1.56 1.81
680.00% 16.03%

25 Analysts have issued a Salesforce forecast for earnings per share. The average Salesforce EPS is $7.23 . This is 12.97% higher than earnings per share in the financial year 2025. The highest EPS forecast is $7.66 19.69% , the lowest is $6.73 5.16% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $6.36 51.43%
2026 $7.23 13.68%
2027 $8.44 16.74%
2028 $10.43 23.58%
2029 $14.23 36.43%

P/E ratio

Current 41.84 5.08%
2026 37.04 11.47%
2027 31.72 14.36%
2028 25.68 19.04%
2029 18.82 26.71%

Based on analysts' sales estimates for 2026, the Salesforce stock is valued at an EV/Sales of 6.00 and an P/S ratio of 6.21 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.40 0.16%
2026 6.00 6.31%
2027 5.50 8.33%
2028 4.99 9.25%
2029 4.42 11.42%
2030 4.11 6.98%

P/S ratio

Current 6.63 0.16%
2026 6.21 6.32%
2027 5.70 8.33%
2028 5.17 9.25%
2029 4.58 11.42%
2030 4.26 6.98%

Current Salesforce Upgrades & Downgrades

Analyst Rating Action Date
Cantor Fitzgerald
Overweight
Overweight
Unchanged Jun 20 2025
Oppenheimer
Outperform
Outperform
Unchanged Jun 10 2025
Cantor Fitzgerald
Overweight
Initiated Jun 03 2025
Citigroup
Neutral
Neutral
Unchanged May 30 2025
Stephens & Co.
Equal-Weight
Equal-Weight
Unchanged May 30 2025
WestPark Capital
Buy
Buy
Unchanged May 29 2025
Bernstein
Underperform
Underperform
Unchanged May 29 2025
Analyst Rating Date
Unchanged
Cantor Fitzgerald:
Overweight
Overweight
Jun 20 2025
Unchanged
Oppenheimer:
Outperform
Outperform
Jun 10 2025
Initiated
Cantor Fitzgerald:
Overweight
Jun 03 2025
Unchanged
Citigroup:
Neutral
Neutral
May 30 2025
Unchanged
Stephens & Co.:
Equal-Weight
Equal-Weight
May 30 2025
Unchanged
WestPark Capital:
Buy
Buy
May 29 2025
Unchanged
Bernstein:
Underperform
Underperform
May 29 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today